# TIMENTIN
> **ANDA062691** · Abbreviated New Drug Application (Generic) · Sponsor: GLAXOSMITHKLINE · Approved 1986-12-19
## Drug
- **FDA Application Number:** ANDA062691
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TIMENTIN
- **Generic name:** Clavulanate Potassium
- **Active ingredients:** CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** GLAXOSMITHKLINE
- **First approval:** 1986-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062691)
---
*MORVS · CC0 1.0*